NCT05713773 - Pharmacodynamics and Pharmacokinetics of 3 New Developed Coated Glucose Beads in 20 Obese Healthy Subjects | Biotech Hunter

Enrollment

20

Participants

Timeline

Start Date

October 25, 2019

Primary Completion Date

December 3, 2019

Study Completion Date

December 3, 2019

Conditions

Metabolic SyndromeObesity

Interventions

DRUG

coated beads glucose (8 g) and caffeine anhydrous

After an overnight fasting of about 10 hours the subjects were administered either glucose (8 g) or glucose (8 g) and caffeine starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position on Day 1.

DRUG

coated beads glucose (8 g) and caffeine anhydrous

After an overnight fasting of about 10 hours the subjects were administered either glucose (8 g) or glucose (8 g) and caffeine starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position on Day 1.

DRUG

coated beads glucose (8 g) and caffeine anhydrous

After an overnight fasting of about 10 hours the subjects were administered either glucose (8 g) or glucose (8 g) and caffeine starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position on Day 1.

DRUG

coated beads glucose (8 g)

After an overnight fasting of about 10 hours the subjects were administered glucose (8 g) starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position on Day 1.

DRUG

uncoated beads glucose (8 g) and caffeine anhydrous

After an overnight fasting of about 10 hours the subjects were administered either glucose (8 g) or glucose (8 g) and caffeine starting at 8:00 (time 0; administration time was staggered beginning at 8:00 for the first group of subjects) in sitting position on Day 1.

Trial Locations (1)

300696

Nova-Clin Medical Research Center S.R.L.,, Timișoara